Filing Details

Accession Number:
0001209191-14-005066
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2014-01-27 16:02:10
Reporting Period:
2014-01-10
Filing Date:
2014-01-27
Accepted Time:
2014-01-27 16:02:10
Original Submission Date:
2014-01-14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206199 G Daniel Welch 3280 Bayshore Boulevard
Brisbane CA 94005
Chairman, Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-10 50,000 $8.73 187,434 No 4 M Direct
Common Stock Disposition 2014-01-10 50,000 $17.00 137,434 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-01-10 50,000 $0.00 50,000 $8.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
275,000 2017-06-08 No 4 M Direct
Footnotes
  1. The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.
  2. Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $17.00 to $17.02 per share. Full information on the numbers of shares sold at each sale price is available upon request.
  3. Fully exercisable.